Cormorant Asset Management, LP insider trades

Name: Cormorant Asset Management, LP Form 4 insider trades
Creator: WaveMan
License: https://wave-man.com/terms

Cormorant Asset Management, LP has filed 14 Form 4s with the SEC that we hold, for EyePoint, Inc. (EYPT) (Reporting owner), Bright Minds Biosciences INC. (DRUG) (Reporting owner), Erasca, Inc. (ERAS) (Director) and AMAM (10% owner), among 9 companies in all. Across all of them we count 14 purchases worth $116.8M and 2 sales worth $10.7M reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($10.7M). The largest single trade was a purchase of 950,000 shares of Erasca, Inc. worth $15.2M, dated 2021-07-20. The first filing on our record is dated 2021-07-22 and the latest 2026-04-30.

EyePoint, Inc. (EYPT)

Reporting owner · 4 filings · 6 purchases and sales

Trade date	Code	Shares	Value as filed	Filed
2023-12-08	P, purchase reported on Form 4	588,235	$10.0M	2023-12-12
2024-01-09	P, purchase reported on Form 4	105,000	$2.2M	2024-01-11
2024-01-11	P, purchase reported on Form 4	750,000	$14.8M	2024-01-11
2024-05-06	P, purchase reported on Form 4	207,153	$2.6M	2024-05-08
2024-05-06	P, purchase reported on Form 4	642,847	$7.5M	2024-05-08
2025-12-04	S, sale reported on Form 4	60,000	$942.0K	2025-12-08

Bright Minds Biosciences INC. (DRUG)

Reporting owner · 2 filings · 2 purchases and sales

Trade date	Code	Shares	Value as filed	Filed
2024-11-04	P, purchase reported on Form 4	184,331	$4.0M	2024-11-06
2026-04-28	S, sale reported on Form 4	109,331	$9.8M	2026-04-30

Erasca, Inc. (ERAS)

Director · 2 filings · 2 purchases and sales

Trade date	Code	Shares	Value as filed	Filed
2021-07-20	P, purchase reported on Form 4	950,000	$15.2M	2021-07-22
2022-12-13	P, purchase reported on Form 4	307,692	$2.0M	2022-12-21

AMAM

10% owner · 1 filing · 2 purchases and sales

Trade date	Code	Shares	Value as filed	Filed
2023-09-15	P, purchase reported on Form 4	1,401,505	$12.7M	2023-09-19
2023-09-18	P, purchase reported on Form 4	751,233	$6.9M	2023-09-19

AMAM

10% owner · 1 filing · 1 purchase or sale

Trade date	Code	Shares	Value as filed	Filed
2023-10-23	P, purchase reported on Form 4	1,307,311	$9.1M	2023-10-25

Biomea Fusion, Inc. (BMEA)

Director, 10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

10% owner · 1 filing · 1 purchase or sale

Trade date	Code	Shares	Value as filed	Filed
2024-02-02	P, purchase reported on Form 4	750,000	$14.2M	2024-02-06

Immuneering Corp (IMRX)

10% owner · 1 filing · 1 purchase or sale

Trade date	Code	Shares	Value as filed	Filed
2021-08-03	P, purchase reported on Form 4	550,000	$8.2M	2021-08-05

Pyxis Oncology, Inc. (PYXS)

Reporting owner · 1 filing · 1 purchase or sale

Trade date	Code	Shares	Value as filed	Filed
2021-10-13	P, purchase reported on Form 4	450,000	$7.2M	2021-10-15

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1583977) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms